Zar Chi Soe
Yeungnam University
20 Papers
Zar Chi Soe is an academic researcher from Yeungnam University. The author has contributed to research in topics: Photothermal therapy & Cancer. The author has an hindex of 12, co-authored 18 publications.
Chat about Author
Papers
Regulatory T cell-targeted hybrid nanoparticles combined with immuno-checkpoint blockage for cancer immunotherapy
Wenquan Ou,Raj Kumar Thapa,Liyuan Jiang,Zar Chi Soe,Milan Gautam,Jae-Hoon Chang,Jee-Heon Jeong,Sae-Kwang Ku,Han-Gon Choi,Chul Soon Yong,Jong Oh Kim +10 more
TL;DR: The tLyp1 peptide‐modified hybrid nanoparticles presented good stability and effective targeting to Treg cells, and they enhanced the effect of imatinib in downregulating Treg cell suppression through inhibition of STAT3 and STAT5 phosphorylation.
174
Folate-targeted nanostructured chitosan/chondroitin sulfate complex carriers for enhanced delivery of bortezomib to colorectal cancer cells
Zar Chi Soe,Bijay Kumar Poudel,Hanh Thuy Nguyen,Raj Kumar Thapa,Wenquan Ou,Milan Gautam,Kishwor Poudel,Sung Giu Jin,Jee-Heon Jeong,Sae-Kwang Ku,Han-Gon Choi,Chul Soon Yong,Jong Oh Kim +12 more
TL;DR: The results suggest that folate-targeted nanoparticle can be effectively applied for efficient chemotherapy of colorectal cancer.
105
Combination of NIR therapy and regulatory T cell modulation using layer-by-layer hybrid nanoparticles for effective cancer photoimmunotherapy.
Wenquan Ou,Liyuan Jiang,Raj Kumar Thapa,Zar Chi Soe,Kishwor Poudel,Jae-Hoon Chang,Sae-Kwang Ku,Han-Gon Choi,Chul Soon Yong,Jong Oh Kim +9 more
TL;DR: A photoimmunotherapy-based strategy involving a combination of photothermal and photodynamic therapies, followed by Treg cell suppression, for eliciting an immune response with IR-780- and imatinib-loaded layer-by-layer hybrid nanoparticles successfully eradicated tumor growth, diminished tumor recurrence, and improved survival in vivo.
105
Transferrin-Conjugated Polymeric Nanoparticle for Receptor-Mediated Delivery of Doxorubicin in Doxorubicin-Resistant Breast Cancer Cells
Zar Chi Soe,Jun Bum Kwon,Raj Kumar Thapa,Wenquan Ou,Hanh Thuy Nguyen,Milan Gautam,Kyung Taek Oh,Han-Gon Choi,Sae-Kwang Ku,Chul Soon Yong,Jong Oh Kim +10 more
TL;DR: Dox/F127&P123-Tf has been tailored, using the principles of nanotherapeutics, to overcome drug-resistant chemotherapy and inhibited cell migration and altered the cell cycle patterns of different cancer cells.
Folate receptor-mediated celastrol and irinotecan combination delivery using liposomes for effective chemotherapy.
Zar Chi Soe,Raj Kumar Thapa,Wenquan Ou,Milan Gautam,Hanh Thuy Nguyen,Sung Giu Jin,Sae-Kwang Ku,Kyung Taek Oh,Han-Gon Choi,Chul Soon Yong,Jong Oh Kim +10 more
TL;DR: The results revealed the successful preparation of Cs and Ir-loaded folate-targeted liposomes (Lipo/Cs/Ir-FA) with a small particle size and polydispersity index, and exhibited higher drug release profiles for both Ir and Cs at pH 5.0 compared to those at physiological pH, favoring cancer cell- Targeted release.
88